Clinical Trial Update: Study of Late Boost Strategies for HIV-uninfected Participants From Protocol RV 144 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating late boost strategies for HIV-uninfected participants from Protocol RV 144; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: HIV Infections | Phase 2 | Status: UNKNOWN